1 |
Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
DOI
|
2 |
Banchereau, J. and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
DOI
|
3 |
Paglia, P., C. Chiodoni, M. Rodolfo, and M. P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183: 317-322.
DOI
|
4 |
Palucka, K. and J. Banchereau. 1999. Dendritic cells: a link between innate and adaptive immunity. J. Clin. Immunol. 19:12-25.
DOI
|
5 |
Paczesny, S., J. Banchereau, K. M. Wittkowski, G. Saracino, J. Fay, and A. K. Palucka. 2004. Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J. Exp. Med. 199: 1503-1511.
DOI
|
6 |
Kim, J. H., Y. Lee, Y. S. Bae, W. S. Kim, K. Kim, H. Y. Im, W. K. Kang, K. Park, H. Y. Choi, H. M. Lee, S. Y. Baek, H. Lee, H. Doh, B. M. Kim, C. Y. Kim, C. Jeon, and C. W. Jung. 2007. Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma. Clin. Immunol. 125: 257-267.
DOI
|
7 |
Baek, S., C. S. Kim, S. B. Kim, Y. M. Kim, S. W. Kwon, Y. Kim, H. Kim, and H. Lee. 2011. Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial. J. Transl. Med. 9: 178.
DOI
|
8 |
Ragde, H., W. A. Cavanagh, and B. A. Tjoa. 2004. Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer. J. Urol. 172: 2532-2538.
DOI
|
9 |
Iwashita, Y., K. Tahara, S. Goto, A. Sasaki, S. Kai, M. Seike, C. L. Chen, K. Kawano, and S. Kitano. 2003. A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol. Immunother. 52: 155-161.
|
10 |
Hirschowitz, E. A., T. Foody, R. Kryscio, L. Dickson, J. Sturgill, and J. Yannelli. 2004. Autologous dendritic cell vaccines for non-small-cell lung cancer. J. Clin. Oncol. 22: 2808-2815.
DOI
|
11 |
Hege, K. M. and D. P. Carbone. 2003. Lung cancer vaccines and gene therapy. Lung Cancer 41 Suppl 1: S103-113.
|
12 |
Fong, L., Y. Hou, A. Rivas, C. Benike, A. Yuen, G. A. Fisher, M. M. Davis, and E. G. Engleman. 2001. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 98: 8809-8814.
DOI
|
13 |
Parkin, D. M., F. Bray, J. Ferlay, and P. Pisani. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108.
DOI
|
14 |
Spira, A. and D. S. Ettinger. 2004. Multidisciplinary management of lung cancer. N. Engl. J. Med. 350: 379-392.
DOI
|
15 |
Lee, S. J., M. J. Kim, S. H. In, S. Baek, and H. Lee. 2005. Immunocell therapy for lung cancer: dendritic cell based adjuvant therapy in mouse lung cancer model. Immune Netw. 5: 36-44.
DOI
|
16 |
Ward, K. A., L. A. Stewart, and A. P. Schwarer. 2006. CD34+-derived CD11c+++ BDCA-1++ CD123++ DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy 8: 130-140.
DOI
|
17 |
Encabo, A., P. Solves, E. Mateu, P. Sepúlveda, F. Carbonell- Uberos, and M. D. Miñana. 2004. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3. Stem Cells 22: 725-740.
DOI
|
18 |
Guo, G., S. Chen, J. Zhang, L. Luo, J. Yu, H. Dong, H. Xu, Z. Su, and L. Wu. 2005. Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood. Vaccine 23: 5225-5230.
DOI
|
19 |
Xu, R. L., Y. Tang, P. L. Ogburn, K. Malinowski, S. Madajewicz, F. Santiago-Schwarz, and Q. Fan. 2004. Implication of delayed TNF-alpha exposure on dendritic cell maturation and expansion from cryopreserved cord blood CD34+ hematopoietic progenitors. J. Immunol. Methods 293: 169-182.
DOI
|
20 |
Baleeiro, R. B., L. B. Anselmo, F. A. Soares, C. A. Pinto, O. Ramos, J. L. Gross, F. Haddad, R. N. Younes, M. Y. Tomiyoshi, P. C. Bergami-Santos, and J. A. Barbuto. 2008. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-alpha in lung cancer. Cancer Immunol. Immunother. 57: 1335-1345.
DOI
|
21 |
Hirschowitz, E. A., T. Foody, G. E. Hidalgo, and J. R. Yannelli. 2007. Immunization of NSCLC patients with antigen- pulsed immature autologous dendritic cells. Lung Cancer 57: 365-372.
DOI
|
22 |
Moser, M. and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1: 199-205.
|
23 |
Martín, P., G. M. del Hoyo, F. Anjuère, S. R. Ruiz, C. F. Arias, A. R. Marín, and C. Ardavín. 2000. Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(−) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors. Blood 96:2511-2519.
|